|
1
|
Van Cutsem E, Sagaert X, Topal B,
Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jeuck TL and Wittekind C: Gastric
carcinoma: Stage migration by immunohistochemically detected lymph
node micrometastases. Gastric Cancer. 18:100–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Songun I, Putter H, Kranenbarg EM, Sasako
M and van de Velde CJ: Surgical treatment of gastric cancer:
15-year follow-up results of the randomised nationwide Dutch D1D2
trial. Lancet Oncol. 11:439–449. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ajani JA, D'Amico TA, Almhanna K, Bentrem
DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, et
al: Gastric cancer, version 3.2016, NCCN clinical practice
guidelines in oncology. J Natl Compr Canc Netw. 14:1286–1312. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Smyth EC, Verheij M, Allum W, Cunningham
D, Cervantes A and Arnold D; ESMO, ; Guidelines Committee, :
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis,
treatment and follow-up. Ann Oncol. 27 Suppl 5:v38–v49. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen L, Shan YS, Hu HM, Price TJ, Sirohi
B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, et al: Management of
gastric cancer in Asia: Resource-stratified guidelines. Lancet
Oncol. 14:e535–e547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ajani JA, Lee J, Sano T, Janjigian YY, Fan
D and Song S: Gastric adenocarcinoma. Nat Rev Dis Primers.
3:170362017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim DH, Choi MG, Noh JH, Sohn TS, Bae JM
and Kim S: Clinical significance of skip lymph node metastasis in
gastric cancer patients. Eur J Surg Oncol. 41:339–345. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Choi YY, An JY, Guner A, Kang DR, Cho I,
Kwon IG, Shin HB, Hyung WJ and Noh SH: Skip lymph node metastasis
in gastric cancer: Is it skipping or skipped? Gastric Cancer.
19:206–215. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qiao R, Liu C, Liu M, Hu H, Liu C, Hou Y,
Wu K, Lin Y, Liang J and Gao M: Ultrasensitive in vivo detection of
primary gastric tumor and lymphatic metastasis using upconversion
nanoparticles. ACS Nano. 9:2120–2129. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Furukawa T, Fu X, Kubota T, Watanabe M,
Kitajima M and Hoffman RM: Nude mouse metastatic models of human
stomach cancer constructed using orthotopic implantation of
histologically intact tissue. Cancer Res. 53:1204–1208.
1993.PubMed/NCBI
|
|
12
|
Fujihara T, Sawada T, Hirakawa K, Chung
YS, Yashiro M, Inoue T and Sowa M: Establishment of lymph node
metastatic model for human gastric cancer in nude mice and analysis
of factors associated with metastasis. Clin Exp Metastasis.
16:389–398. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hackl C, Man S, Francia G, Milsom C, Xu P
and Kerbel RS: Metronomic oral topotecan prolongs survival and
reduces liver metastasis in improved preclinical orthotopic and
adjuvant therapy colon cancer models. Gut. 62:259–271. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Van den Broeck W, Derore A and Simoens P:
Anatomy and nomenclature of murine lymph nodes: Descriptive study
and nomenclatory standardization in BALB/cAnNCrl mice. J Immunol
Methods. 312:12–19. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bhargava S, Hotz B, Buhr HJ and Hotz HG:
An orthotopic nude mouse model for preclinical research of gastric
cardia cancer. Int J Colorectal Dis. 24:31–39. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yin J, Cui Y, Li L, Ji J and Jiang WG:
Overexpression of EPHB4 is associated with poor survival of
patients with gastric cancer. Anticancer Res. 37:4489–4497.
2017.PubMed/NCBI
|
|
17
|
Belkhiri A, Dar AA, Zaika A, Kelley M and
El-Rifai W: t-Darpp promotes cancer cell survival by up-regulation
of Bcl2 through Akt-dependent mechanism. Cancer Res. 68:395–403.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo B, Zhao Z, Wang Z, Li Q, Wang X, Wang
W, Song T and Huang C: MicroRNA-302b-3p suppresses cell
proliferation through AKT pathway by targeting IGF-1R in human
gastric cancer. Cellular Physiol Biochem. 42:1701–1711. 2017.
View Article : Google Scholar
|
|
19
|
Burgermeister E, Xing X, Röcken C, Juhasz
M, Chen J, Hiber M, Mair K, Shatz M, Liscovitch M, Schmid RM and
Ebert MP: Differential expression and function of caveolin-1 in
human gastric cancer progression. Cancer Res. 67:8519–8526. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boku N: HER2-positive gastric cancer.
Gastric Cancer. 17:1–12. 2014. View Article : Google Scholar : PubMed/NCBI
|
